糖尿病认知功能障碍发病机制的研究进展
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v2i5.3216
Abstract
糖尿病认知功能障碍是糖尿病常见的神经系统并发症之一,以记忆力减退、认知功能障碍为主要表现。2型糖尿病是引起认知障碍的重要危险因素[1]。随着生活方式的改变和人口的老龄化,糖尿病认知功能障碍的发病率急剧上升,关于该病的研究也越来越多。早期预防和治疗糖尿病认知功能障碍可以降低痴呆的发生率,提高糖尿病患者的生活质量。本文对糖尿病认知功能障碍机制进行阐述。
Keywords
糖尿病；认知功能；机制；分析
Full Text
PDF - Viewed/Downloaded: 0 TimesIndexation
Download Index RecordReferences
[1] Riederer P, Korczyn A D, Ali S S,et al.The diabetic brain and cognition [J].Journal of Neural Transmission,2017, 124(11):1431-1454.
[2] Rao R, Nashawaty M, Fatima S, et al. Neonatal hyperglycemia alters the neurochemical profile, dendritic arborization and gene expression in the developing rat hippocampus[J].NMR in Biomedicine,2018,31(5):e3910.
[3] Valente T,Gella A,FernàndezBusquets X, et al.Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus[J]. Neurobiology of disease,2010,37(1):67-76.
[4] Prasad S, Sajja R K, Naik P, et al. Diabetes mellitus and blood-brain barrier dysfunction:an overview[J].Journal of pharmacovigilance,2014,2(2):125.
[5] Phiel C J, Wilson C A, Lee V M Y, et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides [J].Nature,2003,423(6938):435.
[6] Callisaya M, Nosaka K. Effects of exercise on type 2 diabetes mellitusrelated cognitive impairment and dementia [J].Journal of Alzheimer's Disease,2017, 59(2):503-513.
[7] Gong Y S, Guo J, Hu K, et al. Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by D-galactose [J].Experimentalgerontology,2016,74:21-28.
[8] Takeuchi M,Yamagishi S.Possible involvement of advanced glycation end-products(AGEs)in the pathogenesis of Alzheimer's disease[J].Current phar maceuticaldesign,2008,14(10):973-978.
[9] Wang S,Jia J.Oxymatrine attenuates diabetes-associated cognitive deficits in rats[J].Acta Pharmacologica Sinica, 2014,35(3):331.
[10] Du G T, Hu M, Mei Z L, et al. Telmisartan treatment ameliorates memory deficits in streptozotocininduced diabetic mice via attenuating cerebral amyloidosis[J].Journal of pharmacologicalsciences,2014:13157FP.
[11] Janelidze S, Hertze J, Nägga K, et al. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype[J].Neurobiology of aging,2017,51:104-112.
[12] Marioni R E, Strachan M W J, Reynolds R M, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study[J]. Diabetes,2010,59(3):710-713.
[13] Gorska-CiebiadaM,Saryusz-Wolska M,Borkowska A, et al. Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment [J].Metabolic brain disease, 2016,31(2): 257-266.
[2] Rao R, Nashawaty M, Fatima S, et al. Neonatal hyperglycemia alters the neurochemical profile, dendritic arborization and gene expression in the developing rat hippocampus[J].NMR in Biomedicine,2018,31(5):e3910.
[3] Valente T,Gella A,FernàndezBusquets X, et al.Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus[J]. Neurobiology of disease,2010,37(1):67-76.
[4] Prasad S, Sajja R K, Naik P, et al. Diabetes mellitus and blood-brain barrier dysfunction:an overview[J].Journal of pharmacovigilance,2014,2(2):125.
[5] Phiel C J, Wilson C A, Lee V M Y, et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides [J].Nature,2003,423(6938):435.
[6] Callisaya M, Nosaka K. Effects of exercise on type 2 diabetes mellitusrelated cognitive impairment and dementia [J].Journal of Alzheimer's Disease,2017, 59(2):503-513.
[7] Gong Y S, Guo J, Hu K, et al. Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by D-galactose [J].Experimentalgerontology,2016,74:21-28.
[8] Takeuchi M,Yamagishi S.Possible involvement of advanced glycation end-products(AGEs)in the pathogenesis of Alzheimer's disease[J].Current phar maceuticaldesign,2008,14(10):973-978.
[9] Wang S,Jia J.Oxymatrine attenuates diabetes-associated cognitive deficits in rats[J].Acta Pharmacologica Sinica, 2014,35(3):331.
[10] Du G T, Hu M, Mei Z L, et al. Telmisartan treatment ameliorates memory deficits in streptozotocininduced diabetic mice via attenuating cerebral amyloidosis[J].Journal of pharmacologicalsciences,2014:13157FP.
[11] Janelidze S, Hertze J, Nägga K, et al. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype[J].Neurobiology of aging,2017,51:104-112.
[12] Marioni R E, Strachan M W J, Reynolds R M, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study[J]. Diabetes,2010,59(3):710-713.
[13] Gorska-CiebiadaM,Saryusz-Wolska M,Borkowska A, et al. Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment [J].Metabolic brain disease, 2016,31(2): 257-266.
Copyright © 2021 薛翔宇, 房辉, 刘嘉琦
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License